| Trial ID: | L6622 |
| Source ID: | NCT01717911
|
| Associated Drug: |
Insulin
|
| Title: |
ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Insulin|DRUG: Metformin|DRUG: Sitagliptin
|
| Outcome Measures: |
Primary: The primary outcome was the comparison of A1C change., The primary outcome was the comparison of A1C change., Dec. 2013 | Secondary: Beta-cell function and insulin sensitivity and the proportion of subjects who reached the treatment target (A1C <7.0% or <6.5% at 6 months)., The secondary efficacy analysis was the beta-cell function and insulin sensitivity calculated from OGTT and the proportion of subjects who reached the treatment target (A1C \<7.0% or \<6.5% at 6 months)., Dec 2013
|
| Sponsor/Collaborators: |
Sponsor: Taipei Veterans General Hospital, Taiwan
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
160
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-09
|
| Completion Date: |
2018-12
|
| Results First Posted: |
|
| Last Update Posted: |
2012-10-31
|
| Locations: |
Taipei Veterans General Hospital, Taipei, 11217, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT01717911
|
